> Detailanzeige
Jonczyk, Rebecca
[VerfasserIn];
Stanislawski, Nils
[VerfasserIn];
Seiler, Lisa K.
[VerfasserIn];
Blume, Holger
[VerfasserIn];
Heiden, Stefanie
[VerfasserIn];
Lucas, Henning
[VerfasserIn];
Sarikouch, Samir
[VerfasserIn];
Pott, Philipp-Cornelius
[VerfasserIn];
Stiesch, Meike
[VerfasserIn];
Hauß, Corinna
[VerfasserIn];
Saletti, Giulietta
[VerfasserIn];
González-Hernández, Mariana
[VerfasserIn];
Kaiser, Franziska Karola
[VerfasserIn];
Rimmelzwaan, Guus
[VerfasserIn];
Osterhaus, Albert
[VerfasserIn];
Blume, Cornelia
[VerfasserIn]
Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections—an Open Observational Study in Lower Saxony, Germany
- [published Version]
Teilen
Literatur-
verwaltung
Direktlink
Zur
Merkliste
Lösche von
Merkliste
Per Email teilen
Auf Twitter teilen
Auf Facebook teilen
Per Whatsapp teilen
- Medientyp: E-Artikel; Sonstige Veröffentlichung
- Titel: Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections—an Open Observational Study in Lower Saxony, Germany
- Beteiligte: Jonczyk, Rebecca [VerfasserIn]; Stanislawski, Nils [VerfasserIn]; Seiler, Lisa K. [VerfasserIn]; Blume, Holger [VerfasserIn]; Heiden, Stefanie [VerfasserIn]; Lucas, Henning [VerfasserIn]; Sarikouch, Samir [VerfasserIn]; Pott, Philipp-Cornelius [VerfasserIn]; Stiesch, Meike [VerfasserIn]; Hauß, Corinna [VerfasserIn]; Saletti, Giulietta [VerfasserIn]; González-Hernández, Mariana [VerfasserIn]; Kaiser, Franziska Karola [VerfasserIn]; Rimmelzwaan, Guus [VerfasserIn]; Osterhaus, Albert [VerfasserIn]; Blume, Cornelia [VerfasserIn]
- Erschienen: Birmingham, Ala. : ASM, 2022
- Erschienen in: Microbiology spectrum 10 (2022), Nr. 1 ; Microbiology spectrum
- Sprache: Englisch
- DOI: https://doi.org/10.15488/12234; https://doi.org/10.1128/spectrum.01512-21
- Schlagwörter: working groups ; SARS-CoV-2 antibody screening ; PCR ; COVID-19 ; subclinical cases ; neutralizing antibodies ; antibody screening tests
- Beschreibung: Despite lockdown measures, intense symptom-based PCR, and antigen testing, the SARS-CoV-2 pandemic spread further. In this open observational study conducted in Lower Saxony, Germany, voluntary SARS-CoV-2 PCR tests were performed from April 2020 until June 2021, supported by serum antibody testing to prove whether PCR testing in subjects with none or few symptoms of COVID-19 is a suitable tool to manage the pandemic. In different mobile stations, 4,817 subjects from three different working fields participated in the PCR testing. Serum antibody screening using the SARS-CoV-2 ViraChip IgG (Viramed, Germany) and the Elecsys Anti-SARS-CoV-2 assay (Roche, Germany) was performed alongside virus neutralization testing. Subjects were questioned regarding comorbidities and COVID-19 symptoms. Fifty-one subjects with acute SARS-CoV-2 infection were detected of which 31 subjects did not show any symptoms possibly characteristic for COVID-19. An additional 37 subjects reported a previous SARS-CoV-2 infection (total prevalence 1.82%). Seroconversion was discovered in 58 subjects with known SARS-CoV-2 infection and in 58 subjects that never had a positive PCR test. The latter had a significantly lower Charlson Comorbidity Index, and one third of them were asymptomatic. In 50% of all seroconverted subjects, neutralizing serum antibodies (NAbs) were detectable in parallel to N/S1 (n = 16) or N/S1/S2 antigen specific antibodies (n = 40) against SARS-CoV-2. NAb titers decreased within 100 days after PCR-confirmed SARS-CoV-2 acute infection by at least 2.5-fold. A relatively high rate of subclinical SARS-CoV-2 infections may contribute to the spread of SARS-CoV-2, suggesting that in addition to other intervention strategies, systematic screening of asymptomatic persons by PCR testing may significantly enable better pandemic control.
-
Anmerkungen:
Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
- Zugangsstatus: Freier Zugang
- Rechte-/Nutzungshinweise: Namensnennung (CC BY)